The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
For those of you that are interested in SAMe and its usage for the treatment of various types of pain, and perhaps other benefits, a number of companies have stopped making SAMe instead what they're now focusing on is what they think is a better or more bioavailable alternative, which is 5-methyltetrahydrofolate or 5-MTHF.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.